We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$826M
AUM Growth
Cap. Flow
+$577M
Cap. Flow %
69.85%
Top 10 Hldgs %
23.05%
Holding
4,682
New
4,618
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$33M
2
AAPL icon
Apple
AAPL
+$32.5M
3
BKNG icon
Booking.com
BKNG
+$28.7M
4
AMZN icon
Amazon
AMZN
+$25.7M
5
BIDU icon
Baidu
BIDU
+$16.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.8%
2 Technology 11.13%
3 Healthcare 8.34%
4 Energy 5.42%
5 Communication Services 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOL icon
1501
Toll Brothers
TOL
$14B
$38K ﹤0.01%
+1,096
New +$35.8K
UAA icon
1502
PUT
Under Armour
UAA
$3B
$38K ﹤0.01%
+622
New +$20.8K
ULTA icon
1503
PUT
Ulta Beauty
ULTA
$20.4B
$38K ﹤0.01%
+82
New +$10.1K
VRNT
1504
PUT
DELISTED
Verint Systems
VRNT
$38K ﹤0.01%
+39
New +$1.14K
PDCO
1505
DELISTED
Patterson Companies, Inc.
PDCO
$38K ﹤0.01%
+786
New +$35.4K
IM
1506
DELISTED
Ingram Micro
IM
$38K ﹤0.01%
+1,367
New +$36K
LNCO
1507
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$38K ﹤0.01%
+3,710
New +$71.2K
ASML icon
1508
CALL
ASML
ASML
$675B
$37K ﹤0.01%
+40
New +$4.06K
BBH icon
1509
VanEck Biotech ETF
BBH
$396M
$37K ﹤0.01%
+318
New +$35.8K
BRKR icon
1510
Bruker
BRKR
$9.2B
$37K ﹤0.01%
+1,896
New +$36.5K
CNQ icon
1511
PUT
Canadian Natural Resources
CNQ
$96.9B
$37K ﹤0.01%
+126
New +$2.06K
EPD icon
1512
PUT
Enterprise Products Partners
EPD
$83.8B
$37K ﹤0.01%
+220
New +$8.13K
FSTR icon
1513
Foster
FSTR
$443M
$37K ﹤0.01%
+771
New +$37.6K
INO icon
1514
PUT
Inovio Pharmaceuticals
INO
$79.8M
$37K ﹤0.01%
+15
New +$1.83K
LE icon
1515
PUT
Lands' End
LE
$361M
$37K ﹤0.01%
+113
New +$5.33K
PPC icon
1516
CALL
Pilgrim's Pride
PPC
$6.82B
$37K ﹤0.01%
+162
New +$5.12K
TM icon
1517
PUT
Toyota
TM
$210B
$37K ﹤0.01%
+79
New +$9.49K
ZBH icon
1518
PUT
Zimmer Biomet
ZBH
$17.7B
$37K ﹤0.01%
+205
New +$21.6K
LFC
1519
CALL
DELISTED
China Life Insurance Company Ltd.
LFC
$37K ﹤0.01%
+66
New +$1.04K
NUAN
1520
DELISTED
Nuance Communications, Inc.
NUAN
$37K ﹤0.01%
+2,972
New +$38.2K
RP
1521
CALL
DELISTED
RealPage, Inc.
RP
$37K ﹤0.01%
+57
New +$1.13K
AKS
1522
DELISTED
AK Steel Holding Corp
AKS
$37K ﹤0.01%
+6,300
New +$39.6K
ECYT
1523
DELISTED
Endocyte, Inc. Common Stock
ECYT
$37K ﹤0.01%
+5,945
New +$36.2K
STRZA
1524
CALL
DELISTED
Starz - Series A
STRZA
$37K ﹤0.01%
+112
New +$3.45K
RPRX
1525
PUT
DELISTED
Repros Therapeutics Inc.
RPRX
$37K ﹤0.01%
+484
New +$4.13K

Similar funds

Simplex Trading's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Simplex Trading, which disclosed 4,682 positions worth $826M. Its ten largest holdings account for 23% of the portfolio.

Its largest position is Gilead Sciences: 319,426 shares worth $30.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, followed by Technology and Healthcare.

  • Simplex Trading's largest Q4 2014 buy was Gilead Sciences: 319,426 shares worth $30.1M.
  • Simplex Trading's ten largest holdings make up 23% of its $826M portfolio in Q4 2014.
  • Simplex Trading disclosed 4,682 positions in Q4 2014, its first 13F filing on record.

Based on Simplex Trading's 13F filing for Q4 2014, filed 4 Mar 2015.